22 Apr 2013

More than a third of the world’s population is at risk of contracting malaria – it is estimated that 100 people, primarily children in Africa, die of malaria every hour of every day every year. Malaria is one of the main obstacles to socio-economic development in Africa. Vaccines are considered to be an important strategy to achieve the ultimate goal of malaria elimination and eradication, in addition to the other effective control measures against malaria.

The third conference in the series – MALARIA VACCINES FOR THE WORLD – MVW 2013 is the follow-up to the successful MVW meeting held in London in 2007 and Washington DC in 2010 and again will offer researchers a fresh new forum to discuss the current status of new malaria vaccines initiatives, vaccine candidates and clinical trials. MVW 2013 will focus attention on ‘Vaccine Issues’ in relation to Malaria as a worldwide disease.

MVW 2013 will be of interest to scientists, physicians and other professionals from the academic, industrial/commercial and governmental/policy/regulatory sectors who have an interest in the development, assessment, trends and deployment of vaccines for the worldwide problem that is malaria.

MVW 2013 is also timed in conjunction with World Malaria Day on Thursday 25th April 2013.